Structure-based design of a superagonist ligand for the vitamin D nuclear receptor.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Chemistry and Biology

• Publication date

  2008-04-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.chembiol.2008.03.016PMID 18420145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.

  2007cited by this paper
• Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.

  2007cited by this paper
• Vitamin D receptor ligands for osteoporosis.

  2006cited by this paper
• Vitamin D signaling is modulated on multiple levels in health and disease.

  2006cited by this paper
• The expanding cosmos of nuclear receptor coactivators.

  2006cited by this paper
• Probing a water channel near the A-ring of receptor-bound 1 alpha,25-dihydroxyvitamin D3 with selected 2 alpha-substituted analogues.

  2006cited by this paper
• Ligand binding domain of vitamin D receptors.

  2006cited by this paper
• The impact of chromatin organization of vitamin D target genes.

  2006cited by this paper
• The vitamin D receptor as a therapeutic target

  2006cited by this paper
• Probing a water channel near the A-ring of receptor-bound 1α,25-dihydroxyvitamin D3 with selected 2α-substituted analogues

  2006influential reference
• Vitamin D and cancer.

  2006cited by this paper
• Noncalcemic actions of vitamin D receptor ligands.

  2005cited by this paper
• Mechanisms for the selective action of Vitamin D analogs.

  2005cited by this paper
• Superagonistic Action of 14-epi-Analogs of 1,25-Dihydroxyvitamin D Explained by Vitamin D Receptor-Coactivator Interaction

  2005influential reference
• Immunophenotypic changes induced on human HL60 leukaemia cells by 1alpha,25-dihydroxyvitamin D3 and 12-O-tetradecanoyl phorbol-13-acetate.

  2005cited by this paper
• Mouse functional genomics requires standardization of mouse handling and housing conditions

  2004cited by this paper
• Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model

  2004cited by this paper
• Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.

  2004cited by this paper
• Antiproliferative role of vitamin D and its analogs – a brief overview

  2003cited by this paper
• Vitamin D: A millenium perspective

  2003cited by this paper
• Structure–function relationships of vitamin D including ligand recognition by the vitamin D receptor

  2003cited by this paper
• Crystal structures of the vitamin D receptor complexed to superagonist 20-epi ligands

  2001influential reference
• Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor.

  2001cited by this paper
• The practical synthesis of vitamin D analogs: a challenge for process research.

  2001cited by this paper
• Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo.

  2000cited by this paper
• Aldose and aldehyde reductases: Correlation of molecular modeling and mass spectrometric studies on the binding of inhibitors to the active site

  2000cited by this paper
• The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.

  2000influential reference
• An approach to multi-copy search in molecular replacement.

  2000cited by this paper
• Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex

  1999cited by this paper
• Binding of aldose reductase inhibitors: correlation of crystallographic and mass spectrometric studies

  1999cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Efficient and versatile synthesis of a-ring precursors of 1α,25-dihydroxy-vitamin D3 and analogues. Application to the synthesis of Lythgoe-Roche phosphine oxide

  1997cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.

  1996cited by this paper
• Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid.

  1995cited by this paper
• 20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.

  1995cited by this paper
• Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α

  1995cited by this paper
• Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid

  1995cited by this paper
• Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.

  1995cited by this paper
• Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily

  1995cited by this paper
• Distinct Conformational Changes Induced by 20-epi Analogues of 1,25-Dihydroxyvitamin D Are Associated with Enhanced Activation of the Vitamin D Receptor (*)

  1995cited by this paper
• Synthesis of hydrindan derivatives related to vitamin D

  1992cited by this paper
• Improved methods for building protein models in electron density maps and the location of errors in these models.

  1991cited by this paper
• 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells.

  1983cited by this paper
• Simonsen Lecture. Synthetic approaches to vitamin D and its relatives

  1981cited by this paper

• Hyperagonism of a Vitamin D Receptor Agonist/Histone Deacetylase Inhibitor Hybrid Molecule.

  2025cites this paper
• First Sila-Vitamin D Analogues: Design, Synthesis, Structural Analysis and Biological Activity.

  2024cites this paper
• Design, Synthesis, Biological Activity, and Structural Analysis of Novel Des-C-Ring and Aromatic-D-Ring Analogues of 1α,25-Dihydroxyvitamin D3.

  2022cites this paper
• The Centennial Collection of VDR Ligands: Metabolites, Analogs, Hybrids and Non-Secosteroidal Ligands

  2022cites this paper
• New Approaches to Assess Mechanisms of Action of Selective Vitamin D Analogues

  2021cites this paper
• Vitamin D and its analogs as anticancer and anti-inflammatory agents.

  2020cites this paper
• Novel calcitriol analogue with an oxolane group: In vitro, in vivo, and in silico studies

  2019cites this paper
• Vitamin D and Its Synthetic Analogs

  2019cites this paper
• Structural Basis for Ligand Activity in Vitamin D Receptor

  2018cites this paper
• Aromatic-Based Design of Highly Active and Noncalcemic Vitamin D Receptor Agonists.

  2018cites this paper
• Synthesis of Side-Chain Locked Analogs of 1α,25-Dihydroxyvitamin D3 Bearing a C17 Methyl Group.

  2018cites this paper
• Mutation goals in the vitamin D receptor predicted by computational methods.

  2018cites this paper
• Specific interactions between vitamin D receptor and ligand depending on its chirality: ab initio fragment molecular orbital calculations

  2018influential citation
• Strategies and limitations associated with in vitro characterization of vitamin D receptor activators

  2018cites this paper
• Structure-activity relationship study of vitamin D analogs with oxolane group in their side chain.

  2017cites this paper
• The Use of Vitamin D Metabolites and Analogues in the Treatment of Chronic Kidney Disease.

  2017cites this paper
• Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.

  2016cites this paper
• Superagonism at G protein‐coupled receptors and beyond

  2016cites this paper
• Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

  2016cites this paper
• Predicted structures of new Vitamin D Receptor agonists based on available X-ray structures.

  2015cites this paper
• Multifunctional and potent roles of the 3-hydroxypropoxy group provide eldecalcitol's benefit in osteoporosis treatment.

  2014cites this paper
• Structural considerations of vitamin D signaling

  2014cites this paper
• Development of vitamin D analogs modulating the pocket structure of vitamin D receptor.

  2014cites this paper
• Functionalization of non-activated C-H bonds in the synthesis of vitamin D metabolites and analogs.

  2014cites this paper
• Modulators of vitamin D nuclear receptor: recent advances from structural studies.

  2014cites this paper
• Investigating the Mechanism Behind the Cytotoxic Effects of Ajulemic Acid (AJA) on Ewing's Sarcoma by Employing SMAP and Sybyl-X1.3 Surflex Dock Software Programs to Find Receptors for AJA

  2014cites this paper
• Recent developments of 2-substituted analogs of 1,25(OH)(2)D(3).

  2013cites this paper
• 3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR.

  2013cites this paper
• Synthesis of new calcitriol analogues with an oxolane moiety in their side chains

  2013cites this paper
• A generalized model and high throughput data analysis system for functional modulation of receptor-agonist systems suitable for use in drug discovery.

  2013cites this paper
• Synthesis of a trans-Hydrindanone, Precursor for the Preparation of Vitamin D Analogues†

  2013cites this paper
• Anticancer steroids: linking natural and semi-synthetic compounds.

  2013cites this paper
• Synthesis of (1α)-1,25-Dihydroxyvitamin D3 with a β-Positioned Seven-Carbon Side Chain at C(12)

  2012cites this paper
• Efficient stable isotope labeling and purification of vitamin D receptor from inclusion bodies.

  2012cites this paper
• Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D₃ analogues with a long side chain at C12 and short C17 side chains.

  2012cites this paper
• Current status of vitamin D signaling and its therapeutic applications.

  2012influential citation
• Structural basis for the accommodation of bis- and tris-aromatic derivatives in vitamin D nuclear receptor.

  2012cites this paper
• Design, synthesis, evaluation, and structure of vitamin D analogues with furan side chains.

  2012cites this paper
• Vitamin D receptor ligands: the impact of crystal structures

  2012cites this paper
• Butyl pocket formation in the vitamin D receptor strongly affects the agonistic or antagonistic behavior of ligands.

  2012cites this paper
• Crystal structure of a vitamin D3 analog, ZK203278, showing dissociated profile.

  2011cites this paper
• A human vitamin D receptor mutant activated by cholecalciferol.

  2011cites this paper
• Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA

  2011cites this paper
• 1α,25(OH)2-3-Epi-Vitamin D3, a Natural Physiological Metabolite of Vitamin D3: Its Synthesis, Biological Activity and Crystal Structure with Its Receptor

  2011cites this paper
• Synthesis and biological evaluation of 1α,25-dihydroxyvitamin D(3) analogues hydroxymethylated at C-26.

  2011cites this paper
• Structural Basis for Ligand Activity in VDR

  2011cites this paper
• Engineering the human vitamin D receptor to bind a novel small molecule: Investigating the structure-function relationship between human vitamin D receptor and various ligands

  2011cites this paper
• Theoretical studies on the structural rearrangement of ligand binding pocket in human vitamin D receptor

  2011cites this paper
• Synthesis and Biological Evaluation of 1 r , 25-Dihydroxyvitamin D 3 Analogues Hydroxymethylated at C-26 †

  2011cites this paper
• Synthesis and biological evaluation of phenolic 4,5-dihydroisoxazoles and 3-hydroxy ketones as estrogen receptor alpha and beta agonists.

  2010cites this paper
• Potent antagonist for the vitamin D receptor: vitamin D analogues with simple side chain structure.

  2010cites this paper
• Genes de reparo do DNA e de susceptibilidade genética em pacientes com melanoma maligno

  2010cites this paper
• Crystal Structure of CYP 24 A 1 , a Mitochondrial Cytochrome P 450 Involved in Vitamin D Metabolism

  2010influential citation
• Design and synthesis of active vitamin D analogs.

  2010cites this paper
• MSITE: a new computational tool for comparison of homological proteins in holo form.

  2010cites this paper
• Crystal structure of CYP24A1, a mitochondrial cytochrome P450 involved in vitamin D metabolism.

  2010cites this paper
• Structure-function relationships and crystal structures of the vitamin D receptor bound 2 alpha-methyl-(20S,23S)- and 2 alpha-methyl-(20S,23R)-epoxymethano-1 alpha,25-dihydroxyvitamin D3.

  2010cites this paper
• Regulation of steroid receptor expression by 1alpha-hydroxyvitamin D5 in hormone-responsive breast cancer cells.

  2009cites this paper
• A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.

  2009cites this paper